The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

aTyr Pharma Inc

Nasdaq: LIFE
Last

(U.S.) $3.25

Today's change-0.15 -4.41%
Updated July 21 3:59 PM EDT. Delayed by at least 15 minutes.
 

aTyr Pharma Inc

Nasdaq: LIFE
Last

(U.S.) $3.25

Today's change-0.15 -4.41%
Updated July 21 3:59 PM EDT. Delayed by at least 15 minutes.

aTyr Pharma Inc crosses below 125-day moving average

aTyr Pharma Inc closed sharply lower Friday, dropping (U.S.)$0.15 or 4.41% to (U.S.)$3.25 and crossing below its 125-day moving average. Shares have lost 1.52% over the last five days, but have gained 51.16% over the last year to date. This security has underperformed the S&P 500 by 4.40% during the last year.

Key company metrics

  • Open(U.S.) $3.45
  • Previous close(U.S.) $3.40
  • High(U.S.) $3.50
  • Low(U.S.) $3.25
  • Bid / Ask(U.S.) $3.15 / (U.S.) $3.75
  • YTD % change+51.16%
  • Volume26,339
  • Average volume (10-day)34,043
  • Average volume (1-month)27,953
  • Average volume (3-month)33,748
  • 52-week range(U.S.) $2.10 to (U.S.) $4.45
  • Beta--
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$2.33
Updated July 21 3:59 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2017Q4/2016Q3/2016Q2/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense13131415
Selling / general / administrative4334
Research & development991011
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--0----
Other operating expenses, total--------
Operating income-13-13-14-15
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-13-13-14-15
Income after tax-13-13-14-15
Income tax, total--0----
Net income-13-13-14-15
Total adjustments to net income--000
Net income before extra. items-13-13-14-15
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-13-13-14-15
Inc. avail. to common incl. extra. items-13-13-14-15
Diluted net income-13-13-14-15
Dilution adjustment--------
Diluted weighted average shares24242424
Diluted EPS excluding extraordinary itemsvalue per share-0.56-0.53-0.58-0.65
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.56-0.53-0.58-0.65